superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-09-30
- Valid until
- 2024-03-31
- Published
- 2023-11-06
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 12,310,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "AbbVie quarterly revenue: 13,927,000,000 United States dollar", as of 2023-09-30 (until 2024-03-31). Claim clm_2E4438989255, https://asof.is/claim/clm_2E4438989255, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm.
APA
AsOf. (2023). AbbVie quarterly revenue: 13,927,000,000 United States dollar (as of 2023-09-30 (until 2024-03-31)) [Record clm_2E4438989255]. Retrieved November 8, 2026, from https://asof.is/claim/clm_2E4438989255 (source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm)
BibTeX
@misc{asof_clm_2E4438989255,
author = {AsOf},
title = {AbbVie quarterly revenue: 13,927,000,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_2E4438989255}},
note = {Claim clm\_2E4438989255, as of 2023-09-30 (until 2024-03-31); source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000045/0001551152-23-000045-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_2E4438989255.md/v1/claims/clm_2E4438989255submit a correction